Why Eli Lilly Stock Is a Smart Buy Now

Eli Lilly's stock is down 20%, but its GLP-1 dominance and new oral pill could spark a rebound. Is now...

22/05/2025

0 views

Cigna Slashes Costs for Weight Loss Drugs

Cigna’s new deal makes weight loss drugs like Wegovy and Zepbound more affordable with $200 copay caps. How will this...

21/05/2025

0 views

Eli Lilly’s stock is soaring, but HSBC’s downgrade hints at trouble ahead. High valuations and fierce competition could spell danger....

28/04/2025

2 views

A new weight-loss pill is shaking up pharma stocks, with one company soaring and rivals sinking. What's next for this...

17/04/2025

0 views